SH5-07 (SH-5-07)

Cat. No.: OB0225WX-2715

Appearance: Solid

Purity: ≥97%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: SH5-07 is a hydroxamic acid-derived inhibitor of STAT3 that exerts its biological effects by suppressing the STAT3 signaling axis in various cellular models.

Synonym: SH5-07; 1456632-41-9; SH5-07 (SH-5-07); 4-(N-(4-Cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-N-hydroxybenzamide; 4-[[(4-Cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-N-hydroxy-benzamide; SH5 07; (SH-5-07; 4-[(4-cyclohexylphenyl)methyl-[2-[methyl-(2,3,4,5,6-pentafluorophenyl)sulfonylamino]acetyl]amino]-N-hydroxybenzamide; 4-(N-(4-Cyclohexylbenzyl)-2-((2,3,4,5,6-pentafluoro-N-methylphenyl)sulfonamido)acetamido)-N-hydroxybenzamide; 4-[[(4-Cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-N-hydroxybenzamide; 4-{N-[(4-cyclohexylphenyl)methyl]-2-(N-methyl-2,3,4,5,6-pentafluorobenzenesulfonamido)acetamido}-N-hydroxybenzamide

CAS No.: 1456632-41-9

Compound CID: 72550504

Formula: C₂₉H₂₈F₅N₃O₅S

Formula Weight: 625.61

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: SH5-07 is utilized in signal transduction research as a specialized inhibitor of STAT3 to investigate the disruption of transcription factor dimerization and its impact on suppressing oncogenic growth.